|
gptkbp:instanceOf
|
gptkb:chemical_compound
gptkb:drug
stimulant
anorectic
|
|
gptkbp:approvedBy
|
1960s
|
|
gptkbp:ATCCode
|
A08AA10
|
|
gptkbp:brand
|
Didrex
|
|
gptkbp:CASNumber
|
156-08-1
|
|
gptkbp:chemicalFormula
|
C17H21N
|
|
gptkbp:contraindication
|
gptkb:cardiovascular_disease
glaucoma
hyperthyroidism
history of drug abuse
|
|
gptkbp:controlledSubstanceActSchedule
|
III
|
|
gptkbp:drugClass
|
amphetamine
anorectic
|
|
gptkbp:eliminationHalfLife
|
4-6 hours
|
|
gptkbp:hasInChIKey
|
JQWZUBHZVJXJAI-UHFFFAOYSA-N
|
|
gptkbp:hasSMILES
|
CC(CC1=CC=CC=C1)N(C)C(C)C2=CC=CC=C2
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
benzphetamine
|
|
gptkbp:IUPACName
|
N,α-dimethyl-N-phenylbenzeneethanamine
|
|
gptkbp:legalStatus
|
Schedule III controlled substance
|
|
gptkbp:manufacturer
|
gptkb:Pfizer
|
|
gptkbp:mechanismOfAction
|
releases dopamine
releases norepinephrine
releases serotonin
|
|
gptkbp:metabolism
|
amphetamine
p-hydroxybenzphetamine
|
|
gptkbp:pregnancyCategory
|
X
|
|
gptkbp:PubChem_CID
|
gptkb:CHEMBL1201202
2317
2227
|
|
gptkbp:relatedTo
|
gptkb:phentermine
amphetamine
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
increased heart rate
nervousness
insomnia
dry mouth
|
|
gptkbp:UNII
|
0H1M31793L
|
|
gptkbp:usedFor
|
obesity treatment
|
|
gptkbp:bfsParent
|
gptkb:Schedule_III_controlled_substances
|
|
gptkbp:bfsLayer
|
7
|